Experts Forecast Cancer Research and Treatment Advances in 2021
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex...
As the year draws to a close, we bring you the final edition of Editors’ Picks for 2020. This monthly roundup features one “must read” article, handpicked by...
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...